Dr. Mehrdad Soleimani, MD

Dr. Soleimani practices at Temecula Valley Hospital in Temecula, California, part of Universal Health Services.

Dr. Soleimani's NPI, 1679869705, was assigned on June 27, 2011. Dr. Soleimani graduated from Ross University School of Medicine in 2007. Dr. Soleimani's California license number on file is A111160.

Dr. Soleimani's primary practice is Temecula Valley Hospital, at 31700 Temecula Pkwy, Temecula, CA 92592 in Riverside County. The practice phone is (951) 331-2200.

Dr. Soleimani's primary practice is Temecula Valley Hospital in Temecula, California, part of Universal Health Services. The medical group on file is EM Alliance. Dmand AI also links Dr. Soleimani to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soleimani practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Soleimani's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Soleimani is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Soleimani's licenses on file in 3 states: California, Ohio and New Jersey.

CMS data shows 639 Medicare services from Dr. Soleimani across 5 procedure codes in 2024, for 451 Medicare patients. Medicare paid $60,968 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 451 Medicare patients who saw Dr. Soleimani in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Soleimani's median patient age at 66, with 54% women.

In 2024, Dr. Soleimani wrote 248 Medicare Part D claims for 168 patients. 90% of them were for generic drugs. CMS names the drug for 92 of them, across 4 drugs with 11 or more claims each, at $714 in total drug cost. In 2023, CMS named 93 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Soleimani for performance year 2024, reported as part of a group. Dr. Soleimani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 71 general payments to Dr. Soleimani from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $567.

Dr. Soleimani graduated from Ross University School of Medicine in 2007.

Dr. Soleimani is in network with 2 carriers, including DE State Medicaid and NV State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.